Clinical Trials Directory

Trials / Completed

CompletedNCT01803126

A Proposed Study of Atherosclerotic Plaques in Leg Arteries

Status
Completed
Phase
Study type
Observational
Enrollment
10 (actual)
Sponsor
Southwest Regional Wound Care Center · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Biofilm has been identified as the major bacterial phenotype contributing to atherosclerosis. It has become very important to evaluate atherosclerosis and the role of biofilm using advanced technologies. It is also important to understand wound biofilm at a genetic and a molecular level.

Detailed description

High throughput pyrosequencing is opening new doors in nucleic acid analysis. 454 Roche has developed sequencing instrumentation which has the ability to sequence not only genomic DNA (gDNA) but also derivatives of messenger RNA (mRNA) and 16s ribosomal DNA (rDNA). This technology has the potential to survey the nucleic acids involved within a mixed population of species, such as atherosclerotic biofilm. In addition to transcriptome science; proteome, metabolome, and other -omic sciences are advancing rapidly. Examining atherosclerotic plaque using transcriptome, proteome, metabolome, and other -omic approaches may provide valuable insight into the wound's microecology.

Conditions

Timeline

Start date
2012-06-01
Primary completion
2017-01-01
Completion
2017-01-01
First posted
2013-03-04
Last updated
2018-06-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01803126. Inclusion in this directory is not an endorsement.